AR069621A1 - Sintesis de paliperidona - Google Patents
Sintesis de paliperidonaInfo
- Publication number
- AR069621A1 AR069621A1 ARP080105347A ARP080105347A AR069621A1 AR 069621 A1 AR069621 A1 AR 069621A1 AR P080105347 A ARP080105347 A AR P080105347A AR P080105347 A ARP080105347 A AR P080105347A AR 069621 A1 AR069621 A1 AR 069621A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- group
- leaving group
- defined above
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- -1 sulfonyloxy Chemical group 0.000 abstract 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 239000000460 chlorine Substances 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- PMXMIIMHBWHSKN-UHFFFAOYSA-N 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCC(O)C4=NC=3C)=NOC2=C1 PMXMIIMHBWHSKN-UHFFFAOYSA-N 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 238000005874 Vilsmeier-Haack formylation reaction Methods 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960001057 paliperidone Drugs 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuesto intermediario de formula (6) y su uso para preparar paliperidona. Reivindicacion 1: Un proceso caracterizado porque comprende: a) acilar bajo condiciones Vilsmeier-Haack o Friedel-Crafts un compuesto de la formula (5): en donde, G se selecciona del grupo que consiste de (i) un grupo saliente tal como halo, por ejemplo, cloro, bromo o iodo; o sulfoniloxi, por ejemplo, metansulfoniloxi, trifluorometansulfoniloxi, bencensulfoniloxi, 4-metilbencensulfoniloxi, o 4-metoxibencensulfoniloxi; (ii) un grupo de la formula (4): en donde, L representa un grupo saliente reactivo; y (iii) un grupo de la formula (3) para formar un compuesto de la formula (6), en donde, R' representa hidrogeno o un grupo alquilo C1-19 y G es como se define con anterioridad; y b) transformar dicho compuesto de la formula (6) con un peroxo-compuesto para formar un compuesto de la formula (1): en donde, R es hidrogeno o grupo acilo C1-20 y G es como se define con anterioridad, y preferentemente G representa dicho grupo saliente, preferentemente cloro.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1254607P | 2007-12-10 | 2007-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR069621A1 true AR069621A1 (es) | 2010-02-03 |
Family
ID=40352126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080105347A AR069621A1 (es) | 2007-12-10 | 2008-12-10 | Sintesis de paliperidona |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7977480B2 (es) |
| EP (1) | EP2235009B1 (es) |
| AR (1) | AR069621A1 (es) |
| CL (1) | CL2008003667A1 (es) |
| ES (1) | ES2436658T3 (es) |
| WO (1) | WO2009074333A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2008003651A1 (es) | 2007-12-10 | 2009-06-19 | Novartis Ag | Compuestos derivados de 3,5-diamino-6-cloropirazinamida sustituida; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una condición inflamatoria o alergica, en particular una enfermedad inflamatoria u obstructiva de las vias respiratorias. |
| US20100010218A1 (en) * | 2008-07-11 | 2010-01-14 | Jiri Bartl | Synthesis of paliperidone |
| WO2010003703A2 (en) * | 2008-07-11 | 2010-01-14 | Synthon B.V. | Paliperidone ketone |
| KR101867988B1 (ko) * | 2016-11-02 | 2018-06-15 | 주식회사 엔지켐생명과학 | 팔리페리돈 중간체 및 이를 이용한 팔리페리돈의 제조방법 |
| CN117777131B (zh) * | 2024-02-27 | 2024-06-11 | 合肥华方医药科技有限公司 | 一种帕利哌酮及其关键中间体的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4804663A (en) | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| US5158952A (en) | 1988-11-07 | 1992-10-27 | Janssen Pharmaceutica N.V. | 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use |
| CA2000786C (en) * | 1988-11-07 | 1999-01-26 | Janssen Pharmaceutica, Naamloze Vennootschap | 3-piperidinyl-1,2-benzisoxazoles |
| ATE184281T1 (de) | 1993-11-23 | 1999-09-15 | Janssen Pharmaceutica Nv | 9-hydroxy-pyrido (1,2-a> pyrimidin-4-on-ether- derivate |
| GB2442619B (en) | 2005-05-04 | 2010-05-26 | Pharmed Medicare Pvt Ltd | Chlorination of sucrose acylates using triphosgene |
| WO2009015828A1 (en) | 2007-07-27 | 2009-02-05 | Synthon B.V. | Paliperidone derivatives |
-
2008
- 2008-12-10 AR ARP080105347A patent/AR069621A1/es unknown
- 2008-12-10 WO PCT/EP2008/010562 patent/WO2009074333A1/en not_active Ceased
- 2008-12-10 ES ES08860056.4T patent/ES2436658T3/es active Active
- 2008-12-10 US US12/331,952 patent/US7977480B2/en not_active Expired - Fee Related
- 2008-12-10 EP EP08860056.4A patent/EP2235009B1/en not_active Not-in-force
- 2008-12-10 CL CL2008003667A patent/CL2008003667A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2436658T3 (es) | 2014-01-03 |
| EP2235009A1 (en) | 2010-10-06 |
| EP2235009B1 (en) | 2013-10-30 |
| US20090156810A1 (en) | 2009-06-18 |
| US7977480B2 (en) | 2011-07-12 |
| WO2009074333A1 (en) | 2009-06-18 |
| CL2008003667A1 (es) | 2010-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8812801A1 (es) | Derivados de carboxamidas azabiciclicas, su preparacion y su aplicación en terapéutica | |
| CO6491116A2 (es) | Derivados de 5-fluoropirimidinona | |
| AR075594A1 (es) | Derivados de ( 2-tienil)-sulfonil-amino-1h-indazol como antagonistas de ccr4 | |
| MX2015000755A (es) | Dispositivo de tratamiento para inodoro. | |
| AR076603A1 (es) | Procedimiento para la fabricacion de productos intermedios de dronedarona | |
| MX2011007998A (es) | Nuevos herbicidas. | |
| UY32517A (es) | Derivados de nicotinamida, su preparación y su aplicación en terapéutica | |
| MY161132A (en) | Novel herbicides | |
| AR069621A1 (es) | Sintesis de paliperidona | |
| UA102289C2 (ru) | Гербициды, полученные из циклопентадиона | |
| EP2399902A4 (en) | PROCESS FOR THE PREPARATION OF 2,3-DI-NONLINEARM ALKYL-2-CYANO STARTERIC ACID DIES | |
| CR20120032A (es) | Derivados de 5-fluoro-2-oxopirimidinona-1(2h)-carboxamida substituida-n1 | |
| TN2012000180A1 (en) | Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists | |
| TN2011000355A1 (en) | Novel microbiocides | |
| MX377644B (es) | 6.7.beta-epóxidos esteroideos como intermedios químicos. | |
| AR090566A1 (es) | Proceso para la produccion de inhibidores de crr | |
| MX2014014138A (es) | Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico. | |
| MX2012001155A (es) | 2-(3-alquiltiobenzoil)ciclohexanodionas y su uso como herbicidas. | |
| UY32635A (es) | Derivados de bis-(sulfonilamino) en terapia 735 | |
| BR112013016637A2 (pt) | processo para a preparação de derivados de 3-alquil-sulfinilbenzoíla | |
| UY33528A (es) | Derivados de oxadiazoles y de piridazinas, su preparacion y su aplicacion en terapeutica | |
| EA201391214A1 (ru) | Композиции, содержащие алкилалкоксисульфонаты, для производства термостабильных пен | |
| PH12012501153A1 (en) | Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds | |
| CO6440547A2 (es) | Derivados de (piridil)-azinilamina sustituido como agentes protectores de plantas | |
| TN2014000329A1 (en) | Method for preparing compound by novel michael addition reaction using water or various acids as additive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |